Akhmal Yusof – CEO, Clinical Research Malaysia (CRM)
Dr Akhmal Yusof, CEO of CRM sheds light on the capacity for all stages of clinical research in Malaysia. He discusses the importance of human resources for the country’s research…
Clinical Research Malaysia (CRM) is a non-profit organization wholly owned by the Government of Malaysia. It was established in June 2012 to promote Malaysia as a preferred global destination for industry sponsored clinical research (ISR). CRM provides a range of services to enable and facilitate sponsors (primarily from the pharmaceutical and medical device industries) and contract research organizations (CROs) to initiate a wide spectrum of clinical trials in Malaysia.
CRM’s key functions encompasses three core components, the first of which is securing clinical trials. This is done through advertising and promotional activities, participation in key conferences, involvement in clinical trial distribution and strategic collaborations with major stakeholders. The second component involves closing the deals through a comprehensive feasibility study, convincing site review operation and implementation of an efficient financial, administration and approval process. The third component is conducting the trials. This is achieved through our high quality Study Coordinators and Principal Investigators, effective standard operating procedures, quality assurance of study sites and support services.
CRM Contact Details
Clinical Research Malaysia
Suite E-10-20, Amcorp Business Suites, Menara Melawangi,
Amcorp Trade Centre, No.18, Jalan Persiaran Barat,
46050 Petaling Jaya, Selangor Darul Ehsan, Malaysia.
T: +603 7960 5153
F: +603 7932 1940
E: contact@clinicalresearch.my
W: www.clinicalresearch.my
Get connected socially,
facebook.com/clinicalresearchmalaysia
twitter.com/clinicalrsrchmy
youtube.com/ClinicalRsrchMy
linkedin.com/company/clinical-research-malaysia
Dr Akhmal Yusof, CEO of CRM sheds light on the capacity for all stages of clinical research in Malaysia. He discusses the importance of human resources for the country’s research…
Clinical Research Malaysia’s CEO discusses the need for Malaysia to focus on high quality pivotal trials rather than simply on a high number of trials. He shares with us the…
Wong Kin Sang, country manager of Lundbeck Malaysia, walks us through the mental health issues’ perception in Malaysia and the important work Lundbeck has done to bring more awareness to…
Dr Hyzan Mohd Yusof, CEO at OSA Technology, tells the story of how he founded the company to address Malaysia’s unmet needs in medical devices as well as his vision…
How Malaysia is setting itself up to provide biosimilars across the Islamic world as well as Asia. Inno Bio Ventures, a Malaysian state-owned company originally set up to create…
Dr Ramli Zainal, the director at National Pharmaceutical Regulatory Agency (NPRA), expresses the continuous work of NPRA to build a strong regulatory ecosystem in Malaysia and the important role that…
Tan Sri Rahman Mamat, chairman of Inno Bio Ventures, provides his vision for biosimilars’ potential in Malaysia, and the progress the company has made in laying the foundations to make…
George Kazzi, general manager of Baxter Malaysia, highlights the main areas of development for his affiliate, including the introduction of more renal dialysis innovation as well as increasing awareness and…
Dr Dhesi Baha Raja, consultant in digital technologies at the Malaysian Ministry of Health, introduces the government’s plan to enter digital health through electronic medical records (EMR) and shares his…
Kshitij Panse, director of Servier Malaysia discusses the company’s planned move into oncology, as well as their strategies to provide an all-round improved patient experience, through education, screening, and e-health.…
Datuk Dr Noor Hisham Abdullah, director general of health at the Ministry of Health of Malaysia unveils the government’s plan to bring healthcare back to the community, and create a…
Dr. Azrul Mohd Khalib, chief executive at the Galen Centre for Health and Social Policy, gives an insight on the current important issues the Malaysian healthcare ecosystem is facing and…
Malaysia’s multi-ethnic population, disease burden, medical infrastructure and research speed, combined with its population’s proficiency in English, make the Southeast Asian nation a potentially excellent regional clinical trials destination. …
Shahnas Oli Mohamed, the managing director of Natural Wellness Holdings Sdn Bhd, expresses the important work that Natural Wellness has done to provide natural healthcare products to Malaysian patients, including…
See our Cookie Privacy Policy Here